Non-Steroidal Anti-Inflammatory Drugs and Melanoma -- A Pooling Project
Non-Steroidal Anti-Inflammatory Drugs and Melanoma -- A Pooling Project
批准号:
7214247
负责人:
JOANNE Marie JETER
金额:
$9.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-21 至 2008-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Melanoma incidence in the United States has increased 15-fold over the last 70 years. Despite prevention efforts targeting sun exposure, the major risk factor for melanoma, the mortality from this disease continues to rise. Therefore, other approaches such as chemoprevention have emerged as areas of investigation. One promising class of medications, non-steroidal anti-inflammatory drugs (NSAIDs), has demonstrated protective effects against melanoma in cell lines and mouse models. We have recently conducted a case-control study in humans that found that subjects taking non-aspirin NSAIDs had a 40% decreased risk of melanoma compared to those who did not take these medications. Based on these results, we propose a study dedicated to investigating our hypothesis that regular use of NSAIDs has a chemoprotective effect against melanoma. We will evaluate this hypothesis by pooling data from the Nurses Health Study and the Health Professionals Follow-up Study to address three specific aims: (1) To confirm our preliminary finding of an inverse relationship between the use of NSAIDs and risk of invasive melanoma; (2) To determine the effects of NSAIDs on risk of melanoma in situ, and (3) To assess the influence of NSAIDs on melanoma invasion, as measured by tumor Breslow depth and growth phase. By pooling these studies, effects can be determined in both men and women, and power is increased for more precise estimates of effect. Through our analysis of existing data from these studies, we hope to identify an agent for clinical chemoprevention trials. Due to the large numbers of individuals taking NSAIDs and the increasing incidence of melanoma, we believe that the detection of an effect will make a significant contribution to the public health. This study proposes to investigate whether regular use of non-steroidal anti-inflammatory drugs (NSAIDs) may protect individuals against melanoma. This question will be addressed using data from the Nurses Health Study and the Health Professionals Follow-up Study, two large groups of health professionals who have provided information about their health for up to 24 years. Due to the large numbers of individuals taking NSAIDs and the increasing incidence of melanoma, we believe that the detection of an effect will make a significant contribution to the public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-Steroidal Anti-Inflammatory Drugs and Melanoma -- A Pooling Project
-
批准号:7289338
-
项目类别:
-
资助金额:$7.71万
-
财政年份:2006
-
负责人:JOANNE Marie JETER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于One Health理念的狂犬病传播风险多源驱动机制与协同防控策略研究
-
批准号:2026JJ82002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙坤
-
依托单位:
重大传染病防治关键技术研究-重大传染病防治关键技术研究-基于One Health的SFTS防治技术体系构建与应用
-
批准号:2025C02186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙继民
-
依托单位:
人兽共患病One Health防控决策路径研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:张晓溪
-
依托单位:
基于 One Health 策略的 mcr 阳性多重耐药
ST34 型沙门菌的流行传播机制及溯源研究
-
批准号:Y24H190002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:罗琦霞
-
依托单位:
西方饮食通过“肠道菌群-Rspo1”轴促进肥胖与肠道吸收的机制研究
-
批准号:82370845
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:洪洁
-
依托单位:
基于One Health理念的人兽共患病防控决策机制及实施路径研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张晓溪
-
依托单位:
One Health 导向下人畜共患病公共危机四维防控体系研究
-
批准号:2019JJ50277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:周为
-
依托单位:
基于时间序列Shapelets的u-Health心电图可解释早期分类研究
-
批准号:61702468
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2017
-
负责人:李桂玲
-
依托单位:
基于One Health理念建立动物职业暴露人群流感监测体系的研究
-
批准号:81473034
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2014
-
负责人:袁俊
-
依托单位:
城镇居民亚健康状态的评价方法学及健康管理模式研究
-
批准号:81172775
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:许军
-
依托单位: